Options: Show MedDRA Preferred Terms, display only 20 labels
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anovulatory cycle | x | |||||||||||||||||||||||||||||||
Carcinogenicity | x | |||||||||||||||||||||||||||||||
Cardiac disorder | x | x | x | |||||||||||||||||||||||||||||
Cardiac failure | x | x | x | x | x | x | x | x | ||||||||||||||||||||||||
Cardiac failure congestive | x | x | x | x | x | x | x | x | ||||||||||||||||||||||||
Diabetes mellitus | x | x | x | |||||||||||||||||||||||||||||
Diabetic ketoacidosis | x | x | x | x | x | x | x | x | x | |||||||||||||||||||||||
Insulin resistance | x | x | x | x | x | x | x | |||||||||||||||||||||||||
Liver disorder | x | |||||||||||||||||||||||||||||||
Macrovascular disease | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||||||||||
Type 1 diabetes mellitus | x | x | x | x | x | x | x | x | x | |||||||||||||||||||||||
Type 2 diabetes mellitus | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||
Weight decreased | x | x | x | x | x | x | x | x | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |